<ѻý>FDA Warns on Using Surgical Device for Aesthetic Skin Proceduresѻý> Agency details potentially life-threatening adverse events with plasma-generating device Mar 14, 2022
<ѻý>Predicting Treatment Response in Inflammatory Muscle Disordersѻý> Swedish registry study elicits factors associated with improvement Feb 16, 2022
<ѻý>Acute Muscle Weakness and Skin Rash Following a Lupus Diagnosisѻý> Clinicians consider many differentials Feb 14, 2022
<ѻý>Two Years On, Tremfya Still Shines in Psoriatic Arthritisѻý> Efficacy increases in long-term extension data Feb 10, 2022
<ѻý>Hair Loss Drugs Ranked in Order of Efficacyѻý> Meta-analysis attempts a head-to-head comparison Feb 07, 2022
<ѻý>Evidence Begins to Gel for Atopic Dermatitis, Multiple Comorbid Conditionsѻý> Atopic, metabolic, cardiovascular, and mental health conditions cited in guideline update Feb 02, 2022
<ѻý>Six Medical ѻý With the Highest Hourly Wagesѻý> Plastic and orthopedic surgery top the list Jan 27, 2022
<ѻý>Psoriasis Patients, Docs Want to Do More to Prevent Heart Problemsѻý> Despite well-known cardiovascular risks, most patients currently undertreated Jan 19, 2022
<ѻý>FDA OKs Two Oral JAK Inhibitors for Refractory Atopic Dermatitisѻý> Once-daily abrocitinib and upadacitinib join topical ruxolitinib in expanding AD market Jan 18, 2022
<ѻý>IL-13 Inhibitor Approved for Adults With Atopic Dermatitisѻý> Significantly greater lesion clearance with tralokinumab in placebo-controlled studies Dec 28, 2021
<ѻý>Doc Fired After Standing Up to Private Equity; RFK Jr.'s Anti-Vax Machineѻý> This past week in healthcare investigations Dec 22, 2021
<ѻý>Think TikTok Is Smarter Than Me? Then I'm Not the Right Doctor for Youѻý> Modern times have fundamentally altered the landscape of healthcare Nov 30, 2021
<ѻý>Signs of Relief From 'Therapeutic Drought' in Atopic Dermatitisѻý> Encouraging results from pipeline agents targeting Tѻý-specific inflammation Nov 09, 2021
<ѻý>Could This Biologic Drug Work in Patients Lacking Its Target?ѻý> Bizarre finding with omalizumab Nov 07, 2021
<ѻý>Dramatic Responses in Cutaneous Sarcoidosis With JAK Inhibitorѻý> More than 80% reduction in disease activity in case series of tofacitinib treatment Nov 07, 2021
<ѻý>Substantial Improvement in Vitiligo With Topical JAK Inhibitorѻý> About 30% of patients had 75% clearance after 6 months, half had 50% clearance Nov 06, 2021
<ѻý>Early Success With New Target in Atopic Dermatitisѻý> Inhibition of Tѻý-related inflammation leads to rapid improvement in disease activity Nov 05, 2021
<ѻý>Topical PDE4 Inhibitor Impresses in Trial of Seborrheic Dermatitisѻý> Rapid, persistent improvement in body surface area, itch, other symptoms with roflumilast Nov 04, 2021
<ѻý>Botox Doc's License Suspended Over Breast, Penis Enhancement Harmsѻý> One patient allegedly required two surgeries to fix penile enhancement gone wrong Oct 21, 2021
<ѻý>FDA to Make Isotretinoin Prescribing Gender Neutralѻý> Revision to risk management program dissociates gender from reproductive categories Oct 18, 2021
<ѻý>Is Private Equity a Dangerous Employer?ѻý> Firms' investments in healthcare continue to expand, at what cost? Oct 14, 2021
<ѻý>FDA Warns on Needle-Free Injection Devices for Facial Fillersѻý> Serious injuries and "irreversible" harm to skin, lips, and eyes reported with unapproved devices Oct 08, 2021
<ѻý>FDA Issues Orders Clarifying Rules for Marketing Sunscreensѻý> But more studies on sunscreen chemicals are still needed, advocacy group says Sep 24, 2021
<ѻý>FDA Approves First Topical JAK Inhibitor for Atopic Dermatitisѻý> Significant skin clearance, reduced itch in majority of patients treated with ruxolitinib cream Sep 22, 2021
<ѻý>Oral Drug Active in Teens With Atopic Dermatitisѻý> Significant improvement at 12 weeks in 42-46% by one index, 68-72% by another Aug 24, 2021
<ѻý>Dual IL-17 Inhibitor Achieves Deep Responses in Hidradenitis Suppurativaѻý> Bimekizumab outclasses placebo, compares favorably with adalimumab Aug 20, 2021
<ѻý>Adalimumab Adds to Surgery Benefits for Hidradenitis Suppurativaѻý> Significantly higher response rates before and after surgery with biologic agent Aug 18, 2021
<ѻý>JAK Inhibitor Tops Mab for Eczemaѻý> New disease-modifying treatment option on the horizon Aug 04, 2021
<ѻý>Third Dose a Charm in Israel? Door-to-Door 'Goons'; Cervids Catch COVID, Too!ѻý> A daily roundup of news on COVID-19 and the rest of medicine Jul 30, 2021
<ѻý>Acne Takes a Toll on Women's Mental Health, Quality of Lifeѻý> Almost half reported self-consciousness, adverse effects on professional, social, personal lives Jul 28, 2021
<ѻý>FDA Approves IVIG for Dermatomyositisѻý> Octagam 10% lands indication for adults following results of ProDERM trial Jul 20, 2021
<ѻý>Shingles Risk Slashed in IBD Patients After Vaccineѻý> Study found certain medications also showed lower incidence rates Jul 20, 2021
<ѻý>Skin Rash Should Be a Huge Red Flag for LVAD Recipients, Group Saysѻý> New phenomenon suggests perils of not performing biopsy in time Jul 07, 2021
<ѻý>Physician Organizations Challenge PA Name Changeѻý> The AMA and AOA release statements against the rebrand Jun 09, 2021
<ѻý>Unhealthy Quest for Lighter Skin Fuels Bleaching Epidemicѻý> Breaking the centuries-old cycle of myths about skin color May 25, 2021
<ѻý>Rituximab Tops Mycophenolate Mofetil for Pemphigus Vulgarisѻý> Sustained complete response rate four times higher with anti-CD20 antibody May 19, 2021
<ѻý>Is This the Most TikTok'd COVID Vaccine Side Effect?ѻý> Dermatologists say there's no issue: 'Happy filling, happy vaccinating' May 12, 2021
<ѻý>No Clarity for Role of Laser Therapy in Vulvar Lichen Sclerosusѻý> Mixed results from two small randomized clinical trials May 10, 2021
<ѻý>Another COVID-19 Side Effect: 'Zoom Dysmorphia'ѻý> As people spend more time on camera, many of them like themselves less and less May 06, 2021